---
title: "Dogwood Therapeutics, Inc. (DWTX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/DWTX.US.md"
symbol: "DWTX.US"
name: "Dogwood Therapeutics, Inc."
industry: "生物技术"
---

# Dogwood Therapeutics, Inc. (DWTX.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [dwtx.com](https://dwtx.com) |

## Company Profile

Dogwood Therapeutics, Inc.是一家处于开发阶段的生物技术公司，专注于开发治疗疼痛和疲劳相关疾病的药物。其主要产品候选药物包括 IMC-1，这是一种固定剂量的法莫克洛韦和塞来昔布的组合，已完成治疗纤维肌痛的 2b 期临床试验；Halneuron，目前正在进行 2b 期临床试验，用于治疗化疗引起的神经性疼痛和癌症疼痛，同时也在进行烧伤和眼部疼痛的临床前试验；以及 IMC-2，这是一种在 2 期临床试验中用于治疗长期新冠和新冠感染后急性后遗症的伐昔洛韦和塞来昔布的组合。该公司之前被称为 Virios Therapeutics, Inc.，后来更名为 Dogwood Thera...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.35 | 272/604 | - | - | - |
| PB | -2.84 | 507/604 | 10.85 | 7.18 | 6.24 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-20T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 33% |
| Overweight | 1 | 33% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.93 |
| Highest Target | 30.00 |
| Lowest Target | 11.69 |

## References

- [Company Overview](https://longbridge.com/en/quote/DWTX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/DWTX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/DWTX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.